Skip to content

L · 0DOL.L

Biofrontera AG

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Drug Manufacturers - Specialty & Generic
Headquarters
Leverkusen 51377

Price · as of 2026-09-07

$2.65

Market cap 106.98M

Price history

Weekly OHLC price history for 0DOL.L, USD per share
WeekOpenHighLowCloseVolume
Apr 22, 2019 – Apr 24, 2019$6.05$6.05$6.05$6.05225
Jun 10, 2019 – Jun 14, 2019$7.12$7.12$7.12$7.1211,834
Jun 17, 2019 – Jun 17, 2019$6.75$6.75$6.75$6.751,526
Jun 24, 2019 – Jun 28, 2019$6.88$7.39$6.88$7.391,950
Jul 1, 2019 – Jul 5, 2019$7.28$7.28$7.06$7.113,263
May 4, 2020 – May 6, 2020$2.64$2.64$2.57$2.57813
Jul 20, 2020 – Jul 23, 2020$2.72$2.72$2.72$2.725,744
Aug 31, 2020 – Sep 1, 2020$3.71$3.71$3.71$3.715,379
Sep 7, 2020 – Sep 9, 2020$3.17$3.17$3.14$3.1411,074
Jan 18, 2021 – Jan 22, 2021$3.07$3.07$2.97$2.974,732
Jan 25, 2021 – Jan 28, 2021$3.07$3.07$2.85$2.859,731
Mar 29, 2021 – Mar 31, 2021$2.32$2.32$2.25$2.2868,567
Jan 31, 2022 – Feb 4, 2022$2.43$2.43$2.36$2.39262,044
Feb 7, 2022 – Feb 9, 2022$2.43$2.43$2.36$2.39196,533
Apr 25, 2022 – Apr 25, 2022$1.10$1.10$1.10$1.102,816
May 9, 2022 – May 10, 2022$1.15$1.15$1.15$1.152,691
Dec 12, 2022 – Dec 12, 2022$1.15$1.15$1.15$1.150
Mar 6, 2023 – Mar 9, 2023$1.15$1.15$1.15$1.150
Apr 17, 2023 – Apr 21, 2023$1.22$1.22$1.22$1.22150
Apr 24, 2023 – Apr 26, 2023$1.17$1.17$1.17$1.17403
Feb 16, 2026 – Feb 18, 2026$2.54$2.71$2.54$2.630
Mar 30, 2026 – Mar 30, 2026$2.62$2.62$2.62$2.6237,200
Apr 20, 2026 – Apr 24, 2026$2.46$2.46$2.46$2.46304
Apr 27, 2026 – Apr 30, 2026$2.50$2.50$2.50$2.500
May 11, 2026 – May 11, 2026$2.56$2.56$2.56$2.561
May 18, 2026 – May 21, 2026$2.44$2.44$2.44$2.441
May 25, 2026 – May 28, 2026$2.48$2.48$2.40$2.402
Jun 29, 2026 – Jul 3, 2026$2.24$2.40$2.24$2.404
Jul 6, 2026 – Jul 10, 2026$2.40$2.41$2.27$2.4112
Jul 13, 2026 – Jul 17, 2026$2.27$2.28$2.27$2.277
Jul 20, 2026 – Jul 24, 2026$2.27$2.56$2.27$2.567
Jul 27, 2026 – Jul 28, 2026$2.65$2.65$2.65$2.650
Aug 10, 2026 – Aug 14, 2026$2.65$2.65$2.30$2.4936
Aug 17, 2026 – Aug 20, 2026$2.50$2.50$2.50$2.501
Aug 24, 2026 – Aug 25, 2026$2.52$2.53$2.52$2.532
Aug 31, 2026 – Sep 4, 2026$2.44$2.44$2.44$2.441
Sep 7, 2026 – Sep 7, 2026$2.55$2.55$2.55$2.552

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Biofrontera AG (0DOL.L) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Biofrontera AG

        Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

        CEO
        Pilar de la Huerta Martinez
        Employees
        88
        Beta
        -0.17

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.